The heterogeneity of changes in incidence and survival among lymphoid malignancies in a 30-year French population-based registry

Abstract

Our specialized population-based registry has allowed us to explore changes in incidence and survival by subtype over the last 30 years. Between 1980 and 2009, 4790 cases of lymphoid malignancies were registered using the International Classification of Diseases for Oncology. The incidence rate of lymphoid malignancies was 20.5 per 100 000 inhabitants per year, and ranged from 0.1 to 4 according to subtype. Five-year net survival was 65%, and ranged from 41% to 93% according to subtype. We observed an increase in 5-year net survival between the periods 1980–1989 and 2000–2009 (58% vs. 70%). This was observed in most but not all subtypes. Our long-standing population-based registry allowed us to measure differences in trends according to the subtype of lymphoid malignancy. Incidence rates steadily increased in quite frequent entities, and poor survival probability for most entities indicates that they should be the next objective in therapeutic research programs.

Keywords::

• Incidence
• survival
• trend
• lymphoid malignancies
• population-based
• cancer registry

Acknowledgements

We thank Philip Bastable for correcting the manuscript.

The Registry of Hematologic Malignancies of Côte d’Or was funded by the Institut de Veille Sanitaire (InVS) and by INSERM.

Potential conflict of interest

Disclosure forms provided by the authors are available with the full text of this article at www.informahealthcare.com/lal.